Get started
Author

Abby Gregory

Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2025 · Peter Joel Hosein, Michael Rothe, et al. · Journal of Clinical Oncology · 3
PDF
Palbociclib in patients (pts) with ovarian cancer (OC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2025 · Dan Steven Veljovich, Michael Rothe, et al. · Journal of Clinical Oncology · 1
PDF
Pertuzumab plus trastuzumab (P+T) in patients (pts) with solid tumors with ERBB2or ERBB3amplification (amp) or mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2024 · Elie G. Dib, Michael Rothe, et al. · Journal of Clinical Oncology · 1
PDF
Afatinib in patients (pts) with solid tumors with neuregulin 1 (NRG1) fusions: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2024 · Jordi Rodon Ahnert, Michael Rothe, et al. · Journal of Clinical Oncology · 1
Nivolumab plus ipilimumab (N+I) in patients (pts) with solid tumors with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
2024 · John K Chan, Michael Rothe, et al. · Journal of Clinical Oncology · 1
Talazoparib (Tala) in patients (pts) with colorectal cancer (CRC) with BRCA1/2 mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2024 · Kathleen J Yost, Michael Rothe, et al. · Journal of Clinical Oncology · 1
Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2024 · Tareq Al Baghdadi, Michael Rothe, et al. · Journal of Clinical Oncology · 1
Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
2025 · John K. Chan, Michael Rothe, et al. · Journal of Clinical Oncology
PDF
Clinician burnout (CBO) research trends from 2013-2022: Results from the State of Cancer Care in America (SOCCA) ASCO Annual Meeting abstract analysis.
2023 · Abby Gregory, Margaret Kelsey Kirkwood, et al. · JCO Oncology Practice
PDF
Works count: 9
Citation count: 9
H-index: 1
I10-index:
Year
Topic
Type